Alterity Gets FDA Nod To Conduct Phase 2 Trial Of ATH434 In Multiple System Atrophy
(RTTNews) - Alterity Therapeutics Ltd. (ATHE), a company focused on neurodegenerative diseases, said on Tuesday that it has received FDA clearance...
Stay updated with breaking news from Multiple System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(RTTNews) - Alterity Therapeutics Ltd. (ATHE), a company focused on neurodegenerative diseases, said on Tuesday that it has received FDA clearance...
San Francisco CA (PRWEB) September 15, 2022 -- Amprion, a leader in diagnostics for neurodegenerative diseases, invites researchers and practitioners
/PRNewswire/ -- Coave Therapeutics ('Coave'), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central...
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics with...
Company to host conference call and webcast on Monday, August 15, 2022, at 8:00am ETBOSTON and ATLANTA, Aug. 12, 2022 /PRNewswire/ -- Inhibikase Thera